Literature DB >> 8689212

Aortic prosthetic infection: 50 patients treated by radical or local surgery.

R J Hannon1, J H Wolfe, A O Mansfield.   

Abstract

Fifty patients with aortic prosthetic infection were managed in a period of 10 years from 1983 to 1993. Twenty-five patients had recurrent sepsis after local surgery (group 1) and 22 of these eventually required radical surgery. Twenty-five patients had radical graft excision as the first procedure (group 2). Group 1 contained an excess of patients with local groin symptoms (11 in group 1 versus five in group 2, P = 0.03) and in this group fewer radiological techniques were used to document the extent of graft infection. The perioperative mortality rate was similar in both groups (seven in group 1 versus five in group 2). The number of amputations was also similar (five in group 1 versus four in group 2). The triad of occlusive disease, aortobifemoral bypass and groin symptoms was associated with eight of nine amputations. While the authors would consider using local techniques if the anastomosis was intact, the graft remained patent and infection appeared to be confined to the groin, this combination is uncommon and radical graft excision remains the preferred treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8689212     DOI: 10.1002/bjs.1800830522

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Surgical and medical interventions for abdominal aortic graft infections.

Authors:  Osamah S Niaz; Ahsan Rao; Ahmed Abidia; Rebecca Parrott; Jonathan Refson; Pranav Somaiya
Journal:  Cochrane Database Syst Rev       Date:  2020-08-05

2.  An unusual case of late graft infection.

Authors:  J Lee; B Lee; B Cranley
Journal:  Ulster Med J       Date:  2000-05

Review 3.  Systematic Review and Meta: Analysis of Aortic Graft Infections following Abdominal Aortic Aneurysm Repair.

Authors:  O S Niaz; A Rao; D Carey; J R Refson; A Abidia; P Somaiya
Journal:  Int J Vasc Med       Date:  2020-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.